These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Predictors for restoration of normal left ventricular function in response to cardiac resynchronization therapy measured at time of implantation. Serdoz LV; Daleffe E; Merlo M; Zecchin M; Barbati G; Pecora D; Pinamonti B; Fantoni C; Lupo P; Di Lenarda A; Sinagra G; Cappato R Am J Cardiol; 2011 Jul; 108(1):75-80. PubMed ID: 21529746 [TBL] [Abstract][Full Text] [Related]
8. Pediatric Dilated Cardiomyopathy Patients Do Not Meet Traditional Cardiac Resynchronization Criteria. Schiller O; Dham N; Greene EA; Heath DM; Alexander ME; Berul CI J Cardiovasc Electrophysiol; 2015 Aug; 26(8):885-889. PubMed ID: 25884372 [TBL] [Abstract][Full Text] [Related]
9. Predictive parameters of left ventricular reverse remodeling in response to cardiac resynchronization therapy in patients with severe congestive heart failure. De Maria E; Gallo P; Damiano M; Scognamiglio G; De Simone C; Nilo S; Guarini P; Mascioli G; Curnis A Ital Heart J; 2005 Sep; 6(9):734-9. PubMed ID: 16212075 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of electrocardiographic measurements before and after cardiac resynchronization device implantation in patients with heart failure due to ischemic or nonischemic cardiomyopathy. Iler MA; Hu T; Ayyagari S; Callahan TD; Civello KC; Thal SG; Wilkoff BL; Chung MK Am J Cardiol; 2008 Feb; 101(3):359-63. PubMed ID: 18237600 [TBL] [Abstract][Full Text] [Related]
11. Cardiac resynchronization therapy in patients with end-stage hypertrophic cardiomyopathy. Killu AM; Park JY; Sara JD; Hodge DO; Gersh BJ; Nishimura RA; Asirvatham SJ; McLeod CJ Europace; 2018 Jan; 20(1):82-88. PubMed ID: 29315424 [TBL] [Abstract][Full Text] [Related]
12. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial. Lenarczyk R; Kowalski O; Sredniawa B; Pruszkowska-Skrzep P; Mazurek M; Jędrzejczyk-Patej E; Woźniak A; Pluta S; Głowacki J; Kalarus Z J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1228-36. PubMed ID: 22651239 [TBL] [Abstract][Full Text] [Related]
13. The Shortest QRS Duration of an Electrocardiogram Might Be an Optimal Electrocardiographic Predictor for Response to Cardiac Resynchronization Therapy. Chen JY; Lin KH; Chang KC; Chou CY Int Heart J; 2017 Aug; 58(4):530-535. PubMed ID: 28701672 [TBL] [Abstract][Full Text] [Related]
14. Absolute survival after cardiac resynchronization therapy according to baseline QRS duration: a multinational 10-year experience: data from the Multicenter International CRT Study. Gasparini M; Leclercq C; Yu CM; Auricchio A; Steinberg JS; Lamp B; Klersy C; Leyva F Am Heart J; 2014 Feb; 167(2):203-209.e1. PubMed ID: 24439981 [TBL] [Abstract][Full Text] [Related]
15. Clinical and electrocardiographic predictors of a positive response to cardiac resynchronization therapy in advanced heart failure. Lecoq G; Leclercq C; Leray E; Crocq C; Alonso C; de Place C; Mabo P; Daubert C Eur Heart J; 2005 Jun; 26(11):1094-100. PubMed ID: 15728648 [TBL] [Abstract][Full Text] [Related]
16. A new simplified electrocardiographic score predicts clinical outcome in patients treated with CRT. Végh EM; Kandala J; Januszkiewicz L; Ren J; Miller A; Orencole M; Blendea D; Merkely B; Gellér L; Singh JP; Borgquist R Europace; 2018 Mar; 20(3):492-500. PubMed ID: 28160485 [TBL] [Abstract][Full Text] [Related]
17. Early Improvement in Mitral Regurgitation after Cardiac Resynchronization Therapy in Cardiomyopathy Patients. Sadeghian H; Lotfi-Tokaldany M; Montazeri M; Kazemi Saeed A; Sahebjam M; Sardari A; Ejmalian G J Heart Valve Dis; 2017 Sep; 26(5):557-563. PubMed ID: 29762924 [TBL] [Abstract][Full Text] [Related]